Financials Alpha MOS

Equities

ALNEO

FR0013421286

Advanced Medical Equipment & Technology

Real-time Euronext Paris 06:10:11 2024-07-01 am EDT 5-day change 1st Jan Change
0.644 EUR +1.26% Intraday chart for Alpha MOS +9.15% -22.78%

Valuation

Fiscal Period: December 2018 2019 2020 2022 2023
Capitalization 1 16.83 6.783 13.4 23.51 8.489
Enterprise Value (EV) 1 15.57 7.774 15.34 26.24 14.15
P/E ratio -2.86 x -6.79 x -3.48 x - -4.56 x
Yield - - - - -
Capitalization / Revenue 3.72 x 1.36 x 3.34 x 3.48 x 1.64 x
EV / Revenue 3.44 x 1.55 x 3.82 x 3.88 x 2.73 x
EV / EBITDA -4.29 x -3.89 x -4.52 x -15.1 x -4.33 x
EV / FCF -3.71 x -16.1 x -1,292 x - -
FCF Yield -26.9% -6.22% -0.08% - -
Price to Book 5.53 x 4.49 x -6.71 x - -2.67 x
Nbr of stocks (in thousands) 46,758 8,478 8,478 10,179 10,179
Reference price 2 0.3600 0.8000 1.580 2.310 0.8340
Announcement Date 5/6/19 6/3/20 4/30/21 4/25/24 4/25/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2022 2023
Net sales 1 4.523 5.004 4.014 6.762 5.183
EBITDA 1 -3.63 -1.996 -3.396 -1.734 -3.269
EBIT 1 -3.828 -2.696 -3.482 -2.364 -3.839
Operating Margin -84.63% -53.88% -86.75% -34.96% -74.07%
Earnings before Tax (EBT) 1 -5.351 -3.349 -3.833 -2.687 -4.743
Net income 1 -5.351 -3.35 -3.846 -2.698 -4.743
Net margin -118.31% -66.95% -95.81% -39.9% -91.51%
EPS 2 -0.1260 -0.1179 -0.4536 - -0.1831
Free Cash Flow 1 -4.192 -0.4838 -0.0119 - -
FCF margin -92.68% -9.67% -0.3% - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 5/6/19 6/3/20 4/30/21 4/25/24 4/25/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1
Net sales -
EBITDA -
EBIT 1 -1.254
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 -1.295
Net margin -
EPS -
Dividend per Share -
Announcement Date 10/28/22
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2022 2023
Net Debt 1 - 0.99 1.95 2.73 5.66
Net Cash position 1 1.26 - - - -
Leverage (Debt/EBITDA) - -0.4965 x -0.5736 x -1.574 x -1.731 x
Free Cash Flow 1 -4.19 -0.48 -0.01 - -
ROE (net income / shareholders' equity) -165% -147% 1,586% 104% 78.3%
ROA (Net income/ Total Assets) -33.2% -25.8% -38.3% -17.7% -31.9%
Assets 1 16.13 13.01 10.04 15.23 14.87
Book Value Per Share 2 0.0700 0.1800 -0.2400 - -0.3100
Cash Flow per Share 2 0.0500 0.1500 0.1200 - 0.0300
Capex 1 1.62 0.37 0.44 - -
Capex / Sales 35.77% 7.31% 10.94% - -
Announcement Date 5/6/19 6/3/20 4/30/21 4/25/24 4/25/24
1EUR in Million2EUR
Estimates